IL-36RN gene: key insights into its role in pediatric pustular psoriasis pathogenesis and treatment

Ye Wang1, Mingyue Li2, Changcheng Hou3

  • 1School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.

PubMed

Insights

Pediatric pustular psoriasis (PPP) is linked to the Interleukin-36 Receptor Antagonist (IL-36RN) gene. Research on IL-36RN

Area of Science:

  • Dermatology
  • Genetics
  • Immunology

Background:

  • Pediatric pustular psoriasis (PPP) is a severe autoimmune skin condition impacting children's well-being.
  • The Interleukin-36 Receptor Antagonist (IL-36RN) gene is crucial in PPP development.

Purpose of the Study:

  • To review current research on the IL-36RN gene in PPP pathogenesis and treatment.
  • To consolidate information on IL-36RN structure, function, mutations, and inheritance.
  • To examine IL-36RN mutation frequency and treatment strategies for different PPP types.

Main Methods:

  • Comprehensive literature review of studies on IL-36RN and PPP.
  • Analysis of gene structure, function, mutation types, and inheritance patterns.
  • Evaluation of mutation frequencies and treatment outcomes in PPP patients.

Main Results:

  • The IL-36RN gene's role in PPP pathogenesis is well-established.
  • Specific IL-36RN mutations are associated with various PPP subtypes.
  • Treatment strategies are being developed based on understanding IL-36RN's function.

Conclusions:

  • IL-36RN is a key factor in pediatric pustular psoriasis.
  • Further research into IL-36RN mutations can guide personalized treatment approaches.
  • This review provides a foundation for advancing PPP research and therapy.